Consider This: Dengue Vaccine (Part 2) — Navigating Cost, Access, and Hesitancy

The Government recently granted conditional approval for Qdenga, the first dengue vaccine to be approved for use in Malaysia. This comes in the wake of an alarming 86% surge in dengue cases last year— with 100 fatalities reported— underscoring an urgent public health challenge. With a national goal of zero dengue-related deaths by 2030, how will the introduction of Qdenga shape Malaysia’s battle against this relentless disease? On this episode of #ConsiderThis Melisa Idris speaks to Professor Dr Sharifa Ezat Wan Puteh, specialist in Health Economy & Public Health at UKM’s Faculty of Medicine.